Organon Receives FDA Approval to Extend NEXPLANON Use to Five Years, Expanding Long-Acting Contraceptive Options for Women Organon a global healthcare company dedicated to improving women’s health outcomes, has announced…
CareDx Announces Inducement Equity Grants to New Employees and Chief Medical Officer Under Nasdaq Listing Rule 5635(c)(4) CareDx, Inc. widely recognized as The Transplant Company™, has announced a new round…
Novanta Prices $550 Million Tangible Equity Units Offering to Bolster Financial Flexibility and Drive Growth Initiatives Novanta Inc. (Nasdaq: NOVT), a leading global technology partner serving medical and advanced technology…
Sarepta Completes ESSENCE Confirmatory Trial for AMONDYS 45 and VYONDYS 53, Reports Encouraging Trends and Strong Pipeline Momentum in Q3 2025 Sarepta Therapeutics, Inc a global leader in precision genetic…
Pharmacy Refusals Create New Hurdles for Patients Seeking Medication Abortion, Despite FDA Approval and Legal Protections In the wake of the U.S. Supreme Court’s 2022 decision to overturn Roe v.…